Daptomycin
These highlights do not include all the information needed to use DAPTOMYCIN FOR INJECTION safely and effectively. See full prescribing information for DAPTOMYCIN FOR INJECTION. DAPTOMYCIN for injection, for intravenous use Initial U.S. Approval: 2003
Approved
Approval ID
07bc65c6-f302-4d16-9803-a8567fe76f38
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 4, 2023
Manufacturers
FDA
Camber Pharmaceuticals, Inc.
DUNS: 826774775
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Daptomycin
PRODUCT DETAILS
NDC Product Code31722-215
Application NumberANDA216445
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateJanuary 4, 2023
Generic NameDaptomycin
INGREDIENTS (2)
DAPTOMYCINActive
Quantity: 350 mg in 7 mL
Code: NWQ5N31VKK
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT